Did You Know?

Editor’s Picks

Latest News

BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™

Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI®) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid Leukemia

S3 Connected Health Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Medical Device Connectivity

Recognized for pioneering advancements that redefine medical device connectivity, accelerate home-based care, and deliver transformative value across global healthcare ecosystems.SAN...

Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radiodiagnostic Candidate 68Ga-PentixaFor in Hypertension

FDA scientific advice meeting provides guidance on planned Phase 3 study of radiodiagnostic lead candidate in treatment-resistant hypertension / primary...

Cosmo Announces Breakthrough Phase III Topline Results from Scalp 1 and Scalp 2 for Clascoterone 5% Solution in Male Hair Loss, Showing up to 539% Relative Improvement in Target-Area Hair Count vs Placebo; US and EU Submissions are Underway

The Frederick Arts Council Presents “Where Energy Meets Matter: Exploring the Frontiers of Science” in partnership with the Frederick National Laboratory for Cancer Research

error: Content is protected !!